![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 5
Zeitschriftenartikel
Pflug, Natali; Cramer, Paula; Robrecht, Sandra; Bahlo, Jasmin; Westermann, Anne; Fink, Anna-Maria; Schrader, Alexandra; Mayer, Petra; Oberbeck, Sebastian; Seiler, Till; Zenz, Thorsten; Duerig, Jan; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Herling, Marco und Hopfinger, Georg
(2019):
New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance.
In: Leukemia & Lymphoma, Bd. 60, Nr. 3: S. 649-657
Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Landau, Dan A.; Bahlo, Jasmin; Robrecht, Sandra; Taylor-Weiner, Amaro N.; Bloehdorn, Johannes; Scheffold, Annika; Mertens, Daniel; Böttcher, Sebastian; Kneba, Michael; Jaeger, Ulrich; Zenz, Thorsten; Wenger, Michael K.; Fingerle-Rowson, Guenter; Wendtner, Clemens; Fink, Anna-Maria; Wu, Catherine J.; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Doehner, Hartmut und Stilgenbauer, Stephan
(2019):
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.
In: Leukemia, Bd. 33, Nr. 9: S. 2183-2194
Cramer, Paula; Tresckow, Julia von; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara und Hallek, Michael
(2018):
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial.
In: Lancet Oncology, Bd. 19, Nr. 9: S. 1215-1228
Fischer, Kirsten; Al-Sawaf, Othman; Fink, Anna-Maria; Dixon, Mark; Bahlo, Jasmin; Warburton, Simon; Kipps, Thomas J.; Weinkove, Robert; Robinson, Sue; Seiler, Till; Opat, Stephen; Owen, Carolyn; Lopez, Javier; Humphrey, Kathryn; Humerickhouse, Rod; Tausch, Eugen; Frenzel, Lukas; Eichhorst, Barbara; Wendtner, Clemens-M.; Stilgenbauer, Stephan; Langerak, Anton W.; Dongen, Jacque J. M. van; Böttcher, Sebastian; Ritgen, Matthias; Göde, Valentin; Mobasher, Mehrdad und Hallek, Michael
(2017):
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
In: Blood, Bd. 129, Nr. 19: S. 2702-2705
Maurer, Christian; Pflug, Natali; Bahlo, Jasmin; Kluth, Sandra; Rhein, Christina; Cramer, Paula; Gross-Ophoff, Carolin; Langerbeins, Petra; Fink, Anna-Maria; Eichhorst, Barbara; Kreuzer, Karl-Anton; Fischer, Norbert; Tausch, Eugen; Stilgenbauer, Stephan; Böttcher, Sebastian; Döhner, Hartmut; Kneba, Michael; Dreyling, Martin; Binder, Mascha; Hallek, Michael; Wendtner, Clemens-Martin; Bergmann, Manuela und Fischer, Kirsten
(2016):
Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.
In: European Journal of Haematology, Bd. 97, Nr. 3: S. 253-260